Caplight Logo









Immuno Nano Med

Immuno Nano Med

Private
Ames, IowaHealthcare & Life Scienceshttps://immunonanomed.com/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$360,000

Company Overview

Immuno Nano Med is a biotechnology company developing room-temperature-stable, dry powder influenza vaccines designed to provide broad, needle-free immunity and eliminate global cold chain dependencies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

needle-free vaccineinhalable vaccineinfluenza vaccinevaccine platformdry powder vaccinethermostable vaccineparticle-based vaccineroom-temperature stablenanoparticle vaccinevaccine deliverynasal vaccinecold-chain freeinfectious diseasepolyanhydride particleself-administrationanimal healthvaccine licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Immuno Nano Med Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Immuno Nano Med Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantNov 19, 2025
GrantOct 1, 2025
GrantAug 22, 2025
AcceleratorAug 22, 2025

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 19, 2025

    $15K raised from University of Iowa John Pappajohn Entrepreneurial Center.

  • Oct 1, 2025

    $305K grant awarded by the National Science Foundation.

Immuno Nano Med Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Immuno Nano Med Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Immuno Nano Med's valuation, stock price, and market status.

Firmographic Details

HeadquartersAmes, Iowa
Employee Range2
Year Founded2020
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.